Annals of Oncology Advance Access originally published online on January 10, 2006
Annals of Oncology 2006 17(7):1173; doi:10.1093/annonc/mdj123
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 European Society for Medical Oncology
letter to the editor |
Weekly oxaliplatin and preoperative radiotherapy as a new neoadjuvant therapy for locally-advanced rectal cancer
| The first 10% of the full text of this article appears below. |
We read with interest Aschele's paper entitled A phase III study of weekly oxaliplatin, 5-fluorouracil continuous infusion and pre-operative radiotherapy in locally advanced rectal cancer in a recent issue of Annals of Oncology [1
]. They addressed the efficacy of weekly Oxaliplatin (OXA), combined with infusional 5-fluorouracil (FUra) and
Department of Surgery, University of Tokyo Hospital, 731, Hongo, Bunkyo-ku, Tokyo, Japan
* (E-mail: WATANABE-1SU@h.u-tokyo.ac.jp)